Panbela Therapeutics
Dr. Simpson joined Panbela as President and Chief Executive Officer in July of 2020 and was also appointed as a Director at that time. She brings to the Company more than 12 years’ experience in pharmaceutical executive leadership, global marketing and product commercialization. Most recently Dr. Simpson was the CEO of Delcath (Nasdaq:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancer.
This person is not in any offices
Panbela Therapeutics
Panbela Therapeutics is a biopharmaceutical company that develops and distributes therapeutics for the treatment of pancreatic cancer.